These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23380051)
1. Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe. Cives M; Ciavarella S; Rizzo FM; De Matteo M; Dammacco F; Silvestris F Cell Signal; 2013 May; 25(5):1108-17. PubMed ID: 23380051 [TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells. Choi M; Kim W; Cheon MG; Lee CW; Kim JE Cancer Lett; 2015 Feb; 357(2):591-601. PubMed ID: 25524551 [TBL] [Abstract][Full Text] [Related]
3. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells. Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402 [TBL] [Abstract][Full Text] [Related]
4. Combination of bendamustine and entinostat synergistically inhibits proliferation of multiple myeloma cells via induction of apoptosis and DNA damage response. Cai B; Lyu H; Huang J; Wang S; Lee CK; Gao C; Liu B Cancer Lett; 2013 Jul; 335(2):343-50. PubMed ID: 23459296 [TBL] [Abstract][Full Text] [Related]
5. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entry. Chang WL; Yu CC; Chen CS; Guh JH Biochem Pharmacol; 2015 Mar; 94(1):12-21. PubMed ID: 25615907 [TBL] [Abstract][Full Text] [Related]
6. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Leoni LM; Bailey B; Reifert J; Bendall HH; Zeller RW; Corbeil J; Elliott G; Niemeyer CC Clin Cancer Res; 2008 Jan; 14(1):309-17. PubMed ID: 18172283 [TBL] [Abstract][Full Text] [Related]
7. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe. Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Liu Y; Wang W; Fang B; Ma F; Zheng Q; Deng P; Zhao S; Chen M; Yang G; He G Eur J Pharmacol; 2013 Jan; 698(1-3):95-102. PubMed ID: 23117090 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation. Vogel C; Hager C; Bastians H Cancer Res; 2007 Jan; 67(1):339-45. PubMed ID: 17210716 [TBL] [Abstract][Full Text] [Related]
10. DITMD-induced mitotic defects and apoptosis in tumor cells by blocking the polo-box domain-dependent functions of polo-like kinase 1. Kim KU; Lee JH; Lee MY; Chae CH; Lee JH; Lee BH; Oh KS Eur J Pharmacol; 2019 Mar; 847():113-122. PubMed ID: 30689997 [TBL] [Abstract][Full Text] [Related]
11. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL). Pu Q; Bianchi P; Bezwoda WR Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327 [TBL] [Abstract][Full Text] [Related]
12. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Hazlehurst LA; Enkemann SA; Beam CA; Argilagos RF; Painter J; Shain KH; Saporta S; Boulware D; Moscinski L; Alsina M; Dalton WS Cancer Res; 2003 Nov; 63(22):7900-6. PubMed ID: 14633719 [TBL] [Abstract][Full Text] [Related]
13. Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteins. Lu B; Li J; Pan J; Huang B; Liu J; Zheng D Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):683-91. PubMed ID: 23688587 [TBL] [Abstract][Full Text] [Related]
14. Proteomic studies of multiple myeloma in RPMI8226 cell line treated with bendamustine. Sun C; Li J; Gu J; Liu J; Huang B J BUON; 2013; 18(4):996-1005. PubMed ID: 24344029 [TBL] [Abstract][Full Text] [Related]
15. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation. Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963 [TBL] [Abstract][Full Text] [Related]
16. Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin. Yoon MJ; Park SS; Kang YJ; Kim IY; Lee JA; Lee JS; Kim EG; Lee CW; Choi KS Carcinogenesis; 2012 Mar; 33(3):492-500. PubMed ID: 22159225 [TBL] [Abstract][Full Text] [Related]
17. Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other. Surget S; Lemieux-Blanchard E; Maïga S; Descamps G; Le Gouill S; Moreau P; Amiot M; Pellat-Deceunynck C Leuk Lymphoma; 2014 Sep; 55(9):2165-73. PubMed ID: 24308434 [TBL] [Abstract][Full Text] [Related]
18. Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines. Strumberg D; Harstrick A; Doll K; Hoffmann B; Seeber S Anticancer Drugs; 1996 Jun; 7(4):415-21. PubMed ID: 8826610 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1. Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882 [TBL] [Abstract][Full Text] [Related]
20. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells. Wolanin K; Magalska A; Mosieniak G; Klinger R; McKenna S; Vejda S; Sikora E; Piwocka K Mol Cancer Res; 2006 Jul; 4(7):457-69. PubMed ID: 16849521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]